NEW YORK, Aug. 27 - EraGen Biosciences said it has been awarded a $100,000 grant from the US National Institutes of Health to develop tests to detect single copies of certain bioweapon agents.
EraGen said it will use its GeneCode technology to test for the existence of so-called Category A organisms, like Bacillus anthracis. R&D work on the tests began earlier this month and will continue for two years, the company said.
Click here for more information.